NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio
LANGHORNE, PA — NEXGEL Inc. (Nasdaq: NXGL) said it will pay $15 million upfront to license and acquire a portfolio of regenerative biomaterial products from Celularity Inc. (Nasdaq: CELU), with …
NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio Read More